Omalizumab is effective in the preseasonal treatment of seasonal allergic rhinitis.

Yuan ZhangLin XiYunbo GaoYanran HuangFeifei CaoWei XiongChengshuo WangLuo Zhang

Published in: Clinical and translational allergy (2022)

Administration of a single injection of 300 mg omalizumab two weeks before start of the pollen season achieves better overall control of symptoms and QoL, with significantly reduced allergy symptoms-relieving medication usage, compared with standard pharmacotherapy in SAR patients.

Keyphrases

allergic rhinitis
end stage renal disease
ejection fraction
newly diagnosed
healthcare
prognostic factors
emergency department
patient reported outcomes
smoking cessation
adverse drug
depressive symptoms
patient reported
preterm birth